Dynamic Characterization of Postoperative Recovery After Cardiac Surgery

Sponsor
China National Center for Cardiovascular Diseases (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05782036
Collaborator
(none)
600
19

Study Details

Study Description

Brief Summary

With the improvement of surgical techniques and medical care levels, most cardiac surgery patients have a good prognosis, and the long-term postoperative survival rate of some surgical patients has not significantly differed from that of the general population. While cardiac surgery is traumatic for patients and has a long postoperative recovery cycle, the recovery of patients is equally of concern. Postoperative recovery is a complex concept involving multiple domains, including patients' physiological functions, mental health, and pain, etc. These states will not only continuously change over time, but also the situation of postoperative recovery in patients with different characteristics is very different. Accordingly, the investigators aim to characterize trajectories of patient recovery after cardiac surgery using PROMs. The investigators will conduct a prospective study to characterize trajectories of postoperative recovery in multiple domains after cardiac surgery.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    600 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Dynamic Characterization of Postoperative Recovery After Cardiac Surgery
    Anticipated Study Start Date :
    Apr 1, 2023
    Anticipated Primary Completion Date :
    Oct 30, 2023
    Anticipated Study Completion Date :
    Oct 30, 2024

    Outcome Measures

    Primary Outcome Measures

    1. EQ-5D results [1 year post operative]

    Secondary Outcome Measures

    1. In-hospital mortality [From surgery to discharge, up to 7 days]

      Occurrence of death during hospitalization

    2. In-hospital stroke [From surgery to discharge, up to 7 days]

      Occurrence of stroke during hospitalization

    3. In-hospital myocardial infarction [From surgery to discharge, up to 7 days]

      Occurrence of myocardial infarction during hospitalization

    4. In-hospital acute renal failure [From surgery to discharge, up to 7 days]

      Occurrence of acute renal failure during hospitalization

    5. In-hospital sternal wound infection [From surgery to discharge, up to 7 days]

      Occurrence of sternal wound infection during hospitalization

    6. In-hospital reoperation [From surgery to discharge, up to 7 days]

      Occurrence of reoperation during hospitalization

    7. Length of hospital stay [Approximately 7 days]

      Length of hospital stay

    8. 1-year major adverse events [1 year post operative]

      Occurrence of 1-year major adverse events (all-cause death, readmission, cardiac related readmission, stroke, myocardial infarction, acute renal failure, dialysis, atrial fibrillation, Peripheral vascular embolism, bleeding, heart failure)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Elective cardiac surgery
    Exclusion Criteria:
    • Emergency surgery

    • Age ≤ 18 years

    • Refuse to participate in this study

    • Duration of postoperative ventilation > 48 hours or other postoperative recovery data were not available

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • China National Center for Cardiovascular Diseases

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    China National Center for Cardiovascular Diseases
    ClinicalTrials.gov Identifier:
    NCT05782036
    Other Study ID Numbers:
    • 2022-1882
    First Posted:
    Mar 23, 2023
    Last Update Posted:
    Mar 23, 2023
    Last Verified:
    Feb 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Mar 23, 2023